Atai Life Sciences N.V.
NASDAQ:ATAI
1.28 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.04 | 0.273 | 0 | 0.018 | 0.087 | 0.172 | 0.037 | 0.038 | 0.024 | 0.17 | 0 | 0.23 | 0.266 | 0 | 19.88 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.082 | 0.083 | 0.101 | 0.074 | 0.195 | 0.167 | 0.053 | 0.036 | 0.019 | 0.06 | 0.029 | 0 | 0.019 | 0 | 0 | 0 | 2.813 | 0 |
| Gross Profit
| 0.04 | 0.191 | -0.083 | -0.083 | 0.013 | -0.023 | -0.13 | -0.015 | -0.012 | 0.151 | -0.06 | 0.201 | 0.266 | -0.019 | 19.88 | 0 | 0 | -2.813 | 0 |
| Gross Profit Ratio
| 1 | 0.7 | 0 | -4.611 | 0.149 | -0.134 | -3.514 | -0.395 | -0.5 | 0.888 | 0 | 0.874 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 12.377 | 12.605 | 11.447 | 14.055 | 13.29 | 15.476 | 19.281 | 21.876 | 19.028 | 17.949 | 15.46 | 19.528 | 13.363 | 16.026 | 5.585 | 3.352 | 3.058 | 2.854 | 2.144 |
| General & Administrative Expenses
| 10.265 | 13.397 | 12.555 | 19.423 | 13.631 | 16.558 | 13.97 | 15.727 | 19.419 | 17.221 | 17.982 | 25.877 | 20.264 | 37.331 | 9.273 | 71.985 | 4.328 | 2.851 | 1.57 |
| Selling & Marketing Expenses
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.265 | 13.397 | 12.455 | 19.423 | 13.631 | 16.558 | 13.97 | 15.727 | 19.419 | 17.221 | 17.982 | 25.877 | 20.264 | 37.331 | 9.273 | 71.985 | 4.328 | 2.851 | 1.57 |
| Other Expenses
| 0 | 0 | -0.005 | -0.111 | 70.681 | 0.204 | 0.058 | -1.756 | -0.1 | -0.012 | 0 | -3.28 | -0.029 | -3.189 | 1.374 | -2.724 | -13.878 | -1.297 | 1.762 |
| Operating Expenses
| 22.642 | 26.002 | 23.902 | 33.478 | 26.921 | 32.034 | 33.251 | 37.603 | 38.447 | 35.17 | 33.442 | 45.405 | 33.627 | 53.357 | 14.858 | 75.337 | 7.386 | 5.705 | 3.714 |
| Operating Income
| -22.602 | -25.729 | -23.985 | -33.561 | -26.834 | -31.862 | -32.534 | -37.565 | -38.423 | -35.357 | -33.442 | -45.175 | -33.361 | -61.319 | 4.05 | -87.237 | -7.386 | -5.825 | -3.714 |
| Operating Income Ratio
| -565.05 | -94.245 | 0 | -1,864.5 | -308.437 | -185.244 | -879.297 | -988.553 | -1,600.958 | -207.982 | 0 | -196.413 | -125.417 | 0 | 0.204 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -3.861 | -31.621 | -1.596 | 15.241 | 70.681 | 0.204 | 0.058 | -1.756 | 5.289 | 4.551 | 1.521 | -3.404 | 6.887 | -5.982 | 1.703 | -6.817 | -13.942 | -1.321 | 21.615 |
| Income Before Tax
| -26.463 | -57.35 | -25.681 | -18.32 | 43.847 | -31.658 | -33.156 | -39.321 | -33.134 | -30.806 | -31.921 | -48.579 | -26.474 | -67.301 | 5.753 | -91.24 | -21.328 | -7.146 | 17.901 |
| Income Before Tax Ratio
| -661.575 | -210.073 | 0 | -1,017.778 | 503.989 | -184.058 | -896.108 | -1,034.763 | -1,380.583 | -181.212 | 0 | -211.213 | -99.526 | 0 | 0.289 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.178 | 0.019 | -0.004 | 0.428 | 0.238 | 0.185 | 0.165 | 6.002 | 0.135 | 0.051 | 0.041 | -4.421 | 0.368 | 0.058 | 0.006 | 0.301 | 0.004 | 9.355 | -18.254 |
| Net Income
| -26.286 | -57.312 | -26.713 | -18.292 | 44.244 | -33.042 | -33.321 | -45.323 | -33.269 | -30.857 | -31.962 | -88.877 | -31.158 | -48.461 | 0.688 | -86.594 | -83.195 | -16.357 | 16.302 |
| Net Income Ratio
| -657.15 | -209.934 | 0 | -1,016.222 | 508.552 | -192.105 | -900.568 | -1,192.711 | -1,386.208 | -181.512 | 0 | -386.422 | -117.135 | 0 | 0.035 | 0 | 0 | 0 | 0 |
| EPS
| -0.16 | -0.36 | -0.17 | -0.12 | 0.28 | -0.21 | -0.21 | -0.29 | -0.22 | -0.2 | -0.21 | -0.59 | -0.21 | -0.37 | 0.005 | -0.57 | -0.55 | -0.11 | 0.11 |
| EPS Diluted
| -0.16 | -0.36 | -0.17 | -0.12 | 0.28 | -0.21 | -0.21 | -0.29 | -0.21 | -0.2 | -0.21 | -0.59 | -0.21 | -0.37 | 0.005 | -0.57 | -0.55 | -0.11 | 0.11 |
| EBITDA
| -25.597 | -56.674 | -24.911 | -17.528 | -26.76 | -30.805 | -32.367 | -37.512 | -33.098 | -30.787 | -31.861 | -38.6 | -33.361 | -53.338 | 5.028 | -75.323 | -7.381 | -5.702 | -3.712 |
| EBITDA Ratio
| -639.925 | -207.597 | 0 | -1,858.889 | -308.437 | -185.244 | -897.676 | -988.553 | -1,817.958 | -229.824 | 0 | -196.413 | -151.387 | 0 | 0.287 | 0 | 0 | 0 | 0 |